ArticleCancer medicine2019

Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population-based cohort study.

Yu-Jui Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.